hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy

Abstract

Acute myeloid leukemia cells are often resistant to radiotherapy and chemotherapy. Here, the authors suggest that hCINAP contributes to the resistance of acute myeloid leukemia cells by regulating SUMOylation of Nucleophosmin during the DNA-damage response.